The effects of lidocaine, hexamethonium and alpha and beta adrenergic blocking agents on the pulmonary veins in intact dogs.
D000083:Acetanilides / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002404:Catheterization; D004285:Dogs; D006584:Hexamethonium Compounds / Q000494:pharmacology*; D007211:Indoles / Q000494:pharmacology; D008012:Lidocaine / Q000494:pharmacology*; D010477:Perfusion; D010636:Phenols / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011651:Pulmonary Artery / Q000187:drug effects; D011667:Pulmonary Veins / Q000187:drug effects*; D013565:Sympatholytics / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects
D000083:Acetanilides; D000605:Amino Alcohols; D006584:Hexamethonium Compounds; D007211:Indoles; D010636:Phenols; D013565:Sympatholytics; D010643:Phenoxybenzamine; D008012:Lidocaine; D010646:Phentolamine